Detalhe da pesquisa
1.
Mechanical properties of the drug-eluting bioresorbable magnesium scaffold compared with polymeric scaffolds and a permanent metallic drug-eluting stent.
Catheter Cardiovasc Interv
; 96(7): E674-E682, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31710149
2.
Bioabsorbable polymer-coated sirolimus-eluting stent implantation preserves coronary vasomotion: A DESSOLVE II trial sub-study.
Catheter Cardiovasc Interv
; 86(7): 1141-50, 2015 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25044635
3.
Vascular compliance changes of the coronary vessel wall after bioresorbable vascular scaffold implantation in the treated and adjacent segments.
Circ J
; 76(7): 1616-23, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22531596
4.
Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and imaging outcomes.
Circulation
; 122(22): 2301-12, 2010 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-21098436
5.
Comparison of in vivo acute stent recoil between the bioresorbable everolimus-eluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus-eluting stent.
Catheter Cardiovasc Interv
; 78(1): 3-12, 2011 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21413120
6.
Short- and mid-term intravascular ultrasound analysis of the new zotarolimus-eluting stent with durable polymer results from the RESOLUTE trial .
Circ J
; 74(10): 2097-102, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20689221
7.
Long-term clinical outcomes of a crystalline sirolimus-eluting coronary stent with a fully bioabsorbable polymer coating: five-year outcomes from the DESSOLVE I and II trials.
EuroIntervention
; 13(18): e2147-e2151, 2018 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29278354
8.
The Polyzene-F Stent Coating Improves Healing and Outcomes Preclinically, but Is It Effective Clinically?
Cardiovasc Revasc Med
; 41: 81-82, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35710897
9.
Comparison of the Absorbable Polymer Sirolimus-Eluting Stent (MiStent) to the Durable Polymer Everolimus-Eluting Stent (Xience) (from the DESSOLVE I/II and ISAR-TEST-4 Studies).
Am J Cardiol
; 117(4): 532-538, 2016 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26762729
10.
Evaluation of a crystalline sirolimus-eluting coronary stent with a bioabsorbable polymer designed for rapid dissolution: two-year outcomes from the DESSOLVE I and II trials.
EuroIntervention
; 12(3): 352-5, 2016 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26403639
11.
A Polylactide Bioresorbable Scaffold Eluting Everolimus for Treatment of Coronary Stenosis: 5-Year Follow-Up.
J Am Coll Cardiol
; 67(7): 766-76, 2016 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-26892411
12.
Serial Multimodality Imaging and 2-Year Clinical Outcomes of the Novel DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold System for the Treatment of Single De Novo Coronary Lesions.
JACC Cardiovasc Interv
; 9(6): 565-74, 2016 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27013155
13.
Chronic arterial responses to polymer-controlled paclitaxel-eluting stents: comparison with bare metal stents by serial intravascular ultrasound analyses: data from the randomized TAXUS-II trial.
Circulation
; 109(2): 196-200, 2004 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-14691036
14.
An independent bench comparison of two bioresorbable drug-eluting coronary scaffolds (Absorb and DESolve) with a durable metallic drug-eluting stent (ML8/Xpedition).
EuroIntervention
; 11(1): 60-7, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25680225
15.
Randomised study of a bioabsorbable polymer-coated sirolimus-eluting stent: results of the DESSOLVE II trial.
EuroIntervention
; 10(12): 1383-90, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24801119
16.
Five-year safety and performance data of a novel third-generation novolimus-eluting bioresorbable scaffold in single de novo lesions.
EuroIntervention
; 15(8): 685-687, 2019 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30530403
17.
A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.
JACC Cardiovasc Interv
; 7(1): 89-99, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24139932
18.
First-in-human evaluation of a sirolimus-eluting coronary stent on an integrated delivery system: the DIRECT study.
EuroIntervention
; 9(1): 46-53, 2013 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23685294
19.
Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial.
JACC Cardiovasc Interv
; 6(10): 999-1009, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24156961
20.
First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
JACC Cardiovasc Interv
; 6(10): 1026-34, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24055443